Craig Tooman joined Silence as Chief Financial Officer in January 2021 and was appointed President, Chief Executive Officer and Executive Director in February 2022. Mr. Tooman has experience in the biopharmaceutical industry spanning more than 30 years, including 15 years of experience as a public company CEO and CFO.
Highly successful international executive with over twenty five years of pharmaceutical… · Experience: Silence Therapeutics plc · Education: University of ...
Craig A Tooman
13 de jun. de 2024 · Craig Tooman is very proud of what Silence Therapeutics has accomplished, and not just because he's the CEO of the company.
CRAIG TOOMAN, AIA, LEED-AP. [email protected]. Craig is a Principal of CTA Architects P.C. and the lead architect for all of the company's school work.
Craig Tooman is the President and Chief Executive Officer at Silence Therapeutics plc. Craig Tooman attended The University of Chicago Booth School of ...
Craig A Tooman is President/CEO at Silence Therapeutics PLC. See Craig A Tooman's compensation, career history, education, & memberships.
Total number of appointments 1. Date of birth: October 1965. SILENCE THERAPEUTICS (LONDON) LIMITED (02757200). Company status: Active.
Craig Tooman joins the Business of Biotech to share how he applies his finance-minded leadership to steward the advance of the company's deepening pipeline of ...
Craig Allen Tooman founded Stockbourne LLC in 2011, where he worked as Principal from 2011 to 2012. Mr. Tooman also currently works at Silence Therapeutics ...
Craig Tooman · Studied at Columbia University · Went to Hawaii Preparatory Academy · Went to St. Stephen's School · Lives in Brooklyn, New York · From Brooklyn, ...